These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20882620)

  • 1. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT; Chen YL; Su WW; Wu HK; Chen RC
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
    Chou CT; Chen YL; Wu HK; Chen RC
    J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
    Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
    J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?
    Haradome H; Grazioli L; Al manea K; Tsunoo M; Motosugi U; Kwee TC; Takaraha T
    J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
    Park YS; Lee CH; Kim BH; Lee J; Choi JW; Kim KA; Ahn JH; Park CM
    Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic acid-enhanced, hepatocyte-phase magnetic resonance images.
    Chen N; Motosugi U; Sano K; Ichikawa T; Nakano M; Morisaka H; Ichikawa S; Matsuda M; Fujii H; Enomoto N; Araki T
    J Comput Assist Tomogr; 2013; 37(3):466-9. PubMed ID: 23674023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
    Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
    Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 10. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease?
    Kwon S; Kim YK; Park HJ; Jeong WK; Lee WJ; Choi D
    Magn Reson Imaging; 2014 Dec; 32(10):1214-22. PubMed ID: 25192607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
    Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
    J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
    Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
    Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.
    Motosugi U; Ichikawa T; Onohara K; Sou H; Sano K; Muhi A; Araki T
    Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
    Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
    Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.